eXoZymes, Inc. EXOZ
Set alert
4.13 USD +0.12 +2.99%
At close · Oct 30
4.11 -0.02 -0.48%
After hours · Oct 30, 4:00 PM ET
4.01 Day range 4.19
3.75 52-week range 16.50
- YTD
- -62.11%
- 1 year
- -67.35%
- Open
- 4.18
- Prev close
- 4.01
- Mkt cap
- 38.43M
- Vol
- 6.11K
- Avg vol
- 8.45K
- EPS
- -1.19
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 4.01
- High
- 4.19
3M chart
Signals (10)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 29, 2026 | 3 days ago |
| RSI: Oversold | Oct 12, 2026 | 2 weeks ago |
| SMA: Bearish | Sep 30, 2026 | 1 month ago |
| SMA: Bearish | Sep 16, 2026 | 1 month ago |
| SMA: Bullish | Sep 11, 2026 | 1 month ago |
| SMA: Bearish | Sep 9, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 8, 2026 | 1 month ago |
| SMA: Bullish | Aug 20, 2026 | 2 months ago |
| SMA: Bullish | Aug 13, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 4, 2026 | 2 months ago |
Financials — quick view
EXOZ Revenue — quarterly 0
EXOZ Net income — quarterly -2.88M
EXOZ EPS — quarterly -0.33
News
- eXoZymes CEO to Discuss Commercialization, Key Milestones, and Potential Catalysts in Fireside Chat with Water Tower Research
- Water Tower Research Publishes Initiation of Coverage Report on eXoZymes, Inc., "Converting Cell-Free Science into a Scalable and Repeatable Commercial Opportunity"
- Head to Head Contrast: Iovance Biotherapeutics (NASDAQ:IOVA) vs. eXoZymes (NASDAQ:EXOZ)
- 12 Health Care Stocks Moving In Wednesday's After-Market Session
- eXoZymes Selects Curia as Commercial-Scale Manufacturing Partner for NCT
- eXoZymes Q2 Earnings Call Highlights
- eXoZymes Q2 Earnings Call Highlights
- 12 Health Care Stocks Moving In Thursday's After-Market Session
- eXoZymes Reports Second Quarter 2026 Results and Provides Business Update at 5PM ET Today
- eXoZymes' NCT Process Achieves 10-fold Productivity Increase, Advancing Beyond Original Commercial-scale Economic Targets
Your note
Sign in to keep a note on EXOZ — it syncs with the Stock Master app.